ABC Arbitrage’s Ascentage Pharma AAPG Stock Holding History

ABC Arbitrage’s Portfolio AAPG Stock Details AAPG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-5,230	Closed	-$204K	–	431
2025 Q3	$204K	Buy	+5,230	New	+$212K	0.02%	196

Other funds holding AAPG

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

XY Capital Central, Hong Kong $101M AUM 1.14% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BIA

Bell Investment Advisors Oakland, California $681M AUM 18.36% 1-Year Est. Return

ABC Arbitrage's AAPG Position: Q4 2025 in Review

ABC Arbitrage sold out of Ascentage Pharma (AAPG) in Q4 2025, closing a stake of 5,230 shares — an estimated $204K sold.

ABC Arbitrage first reported a position in AAPG in Q3 2025 and held it in 1 quarter. The position peaked at $204K in Q3 2025. 12 funds tracked by Wall St. Rank hold AAPG as of Q4 2025.

ABC Arbitrage reported no remaining Ascentage Pharma position as of Q4 2025 after selling out during the quarter.
ABC Arbitrage sold 5,230 Ascentage Pharma shares in Q4 2025, an estimated $204K.
ABC Arbitrage first reported a position in Ascentage Pharma in Q3 2025 and held it in 1 quarter.
ABC Arbitrage's Ascentage Pharma position peaked at $204K in Q3 2025.
12 funds tracked by Wall St. Rank held Ascentage Pharma as of Q4 2025.

Based on ABC Arbitrage's 13F filing for Q4 2025, filed 4 Feb 2026.